55135-132Level 3
TRODELVY (SACITUZUMAB GOVITECAN)
**Product type:** Human Prescription Drug
**Active ingredient:** SACITUZUMAB GOVITECAN
**Strength:** 180 mg/1
**Dosage form:** Powder, For Solution
**Route:** Intravenous
**Labeler:** Gilead Sciences, Inc.
**Marketing category:** BLA (BLA761115)
GET
/api/v1/systems/ndc_fda/nodes/55135-132Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.